This process might therefore hint towards why NfL CSF and plasma levels are increased in several neurological disorders which are per definition p-tau positive, such as AD, frontotemporal dementia and multiple system atrophy [15, 16, 63]. This evidence concerns the gene NEFL and Alzheimer disease.